ERBB2 and breast cancer: Because early‐stage HER2+ breast cancer is highly curable with available therapeutic modalities,2, 5, 7, 11 the staging (or more accurately, classification) and treatment planning should differ from those cancer types with poor prognosis (e.g., pancreatic cancer, triple‐negative breast cancer).